Dr. Naveed A. Rana, MD

Dr. Rana practices at Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance.

Dr. Rana's NPI, 1609863380, was assigned on September 29, 2005. Dr. Rana holds Indiana license 01083275A.

Dr. Rana's primary practice is Franciscan Health Indianapolis, at 8111 S Emerson Ave, Indianapolis, IN 46237 in Marion County. The practice phone is (317) 528-5000.

Dr. Rana's primary practice is Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance. Dr. Rana is also affiliated with IU Health Methodist Hospital. The medical group on file is Franciscan Physician Network. Dmand AI also links Dr. Rana to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rana practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rana's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Rana's licenses on file in 2 states: Indiana and Rhode Island.

CMS data shows 1,544 Medicare services from Dr. Rana across 10 procedure codes in 2024, for 576 Medicare patients. Medicare paid $118,281 for them.

CMS counts 576 Medicare patients who saw Dr. Rana in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rana's median patient age at 72, with 56% women.

In 2024, Dr. Rana wrote 2,354 Medicare Part D claims for 387 patients. 69% of them were for generic drugs. CMS names the drug for 2,049 of them, across 45 drugs with 11 or more claims each, at $5,663,445 in total drug cost. In 2023, CMS named 1,467 claims across 37 drugs.

Dr. Rana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rana as offering telehealth.

Dmand AI links 2 papers to Dr. Rana. Dr. Rana's most frequent co-authors are Cannon Milani, MD and Hande Hayirlioglu Tuncer, MD.

Dmand AI links Dr. Rana to 8 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 116 general payments to Dr. Rana from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $414.